Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Neuromuscular taping in multiple sclerosis. A pilot study.
Correction: Adherence to Interferon β-1b Treatment in Patients with Multiple Sclerosis in Spain.
The next generation of exoskeletons: lighter, cheaper devices are in the works.
Treatment with laquinimod reduces development of active MRI lesions in relapsing MS.
Accentia Biopharmaceuticals Announces that Revimmune Autoimmune Disease Therapy is Featured in Peer-review Journal
Subcortical and Cortical Gray Matter Atrophy in a Large Sample of Patients with Clinically Isolated Syndrome and Early Relapsing-Remitting Multiple Sclerosis.
Parallel states of pathological Wnt signaling in neonatal brain injury and colon cancer.
Toll-like receptors in central nervous system injury and disease: A focus on the spinal cord.
Removing confounding factors via constraint-based clustering: An application to finding homogeneous groups of multiple sclerosis patients.
Newly diagnosed multiple sclerosis in state of Qatar.
Magnetic Resonance Spectroscopy to Assess NeuroInflammation and Neuropathic Pain.
Quality of life in the care home: a qualitative study of the perspectives of residents with multiple sclerosis.
Homophilic interaction of the L1 family of cell adhesion molecules.
[The comparative study of efficacy and tolerability of intramuscular introduction of beta-interferon-1a in adults and adolescents with remitting multiple sclerosis.]
Natalizumab affects the T-cell receptor repertoire in patients with multiple sclerosis.
From classic to spontaneous and humanized models of multiple sclerosis: Impact on understanding pathogenesis and drug development.
Can smoking aggravate my multiple sclerosis symptoms?
A randomized trial of stress management for the prevention of new brain lesions in MS.
Systemic inflammation in progressive multiple sclerosis involves follicular T-helper, th17- and activated B-cells and correlates with progression.
CNS myelin wrapping is driven by actin disassembly.
Clinical Assessment of Orofacial Manifestations in 500 Patients With Multiple Sclerosis.
Accuracy of StepWatch™ and ActiGraph Accelerometers for Measuring Steps Taken among Persons with Multiple Sclerosis.
Lack of confirmation of anti-inward rectifying potassium channel 4.1 antibodies as reliable markers of multiple sclerosis.
Strategies for myelin regeneration: lessons learned from development.
Relationship between Sustained Disability Progression and Functional System Scores in Relapsing-Remitting Multiple Sclerosis: Analysis of Placebo Data from Four Randomized Clinical Trials.

Pages